Endo Flashcards
what is the diagnosis based off these TFTs
TSH=high
T3=
T4=low
Hashimotos
De quervains
Atrophic thyroiditis
what is the diagnosis based off these TFTs
TSH= high
T3=
T4= normal
subclinical hypothyroidism
with subclinical hypo/hyperthyroidism what should you look at to figure out which one it is
TSH
high= hypo (due to t4 being low tsh rises)
low= hyper (due to t4 being high tsh falls)
what is subclinical hypo/hyperthyroidism
when the thyroid is under some stress but is still able to maintain t3/t4 at an appropriate level
it may progress to full blown hypo/hyperthyroidism but not there yet
what is the diagnosis based off these TFTs
TSH= high
T3=
T4= high
TSH secreting tumor
what is the diagnosis based off these TFTs
TSH= low
T3= high
T4= high
graves disease
toxic multinodular goitre
drugs
what is the diagnosis based off these TFTs
TSH= low
T3= normal
T4= normal
subclinical hyperthyrodism
what is the diagnosis based off these TFTs
TSH= low
T3=
T4= low
secondary hypothyroidism
t4 is low because tsh is low
what is the diagnosis based off these TFTs
TSH= low or high
T3= low
T4= low
sick euthyroid
outline the core principles of diabetes management (dont include pharmacology)
- refer to diabetes center for individualised care plan
- refer to support groups
- discuss lifestyle measures
- monitor HbA1c 3-6 monthly until stable on medication
- consider htn and lipid control
how is T1DM managed
insulin therapy
patient education on monitoring glucose and optimal targets
how is T2DM pharmacologically mx
FIRST LINE
- cardiovasc risk?
yes= metformin+SGLT2 inhibitor
no= metformin - GI risk?
yes= modified release metformin - metformin contraindicated?
cv risk= SGLT2 monotherapy
no cv risk= DPP4 inhibitor/pioglitazone/sulfonylurea
SECOND LINE
add SGLT2/DPP4/pioglitazone/sulfonylura
THIRD LINE
add another or insulin based therapy
FOURTH LINE
switch for GLP-1 mimetic if BMI>35 or occupational limits regarding insulin therapy
switch medication
SLGT2 inhibitors end in
FLOZIN
flow like blood so good for heart
DDP4 inhibitors end in
GLIPTIN
GLP-1 mimetics end in
TIDE
GLP 1 mimetics moa
increase insulin secretion
reduce glucagon secretion
SGLT-2 inhibitors moa
reduce glucose reabsorption in kidney
increase urinary glucose excretion
DPP-4 inhibitors moa
decreases breakdown of GLP-1 in small intestine
what diabetes medication is good for not causing weight gain
DDP4 inhibitor
what diabetes medication helps with weight loss
SGLT-2 inhibitors
sulphonylurea moa
increases insulin secretion
sulphonylurea example
gliclazide
pioglitazone is a
thiazolidinedione
pioglitazone moa
reduces peripheral insulin secretion